NCT02651337

Brief Summary

The objective of this pilot study is to perform a set of pressure and flow rate measurements in order to quantitatively characterize safe irrigation or "flushing" of a ventricular shunt catheter, a routine maneuver performed by a neurosurgeon during a shunt revision surgery. This maneuver involves injecting saline with a syringe to clear plugged shunt catheters. Based on data obtained in Stage I of the study, a device has been fabricated which provides the same small-volume pulse of fluid used by surgeons. In Stage II of the study, pressure and flow rate measurements generated by this specialized flusher device will be collected and measured.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2016

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 21, 2015

Completed
21 days until next milestone

First Posted

Study publicly available on registry

January 11, 2016

Completed
3 months until next milestone

Study Start

First participant enrolled

April 1, 2016

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 4, 2016

Completed
10 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 14, 2016

Completed
4.3 years until next milestone

Results Posted

Study results publicly available

September 21, 2020

Completed
Last Updated

September 21, 2020

Status Verified

August 1, 2020

Enrollment Period

2 months

First QC Date

December 21, 2015

Results QC Date

July 16, 2020

Last Update Submit

September 17, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • To Demonstrate That the Flusher Can be Primed, Connected, and Activated in a Sterile Clinical Setting Per the Instructions for Use by the Treating Investigator .

    Criteria for success: Investigator Determination if the Flusher can be properly primed. Investigator Determination if the Flusher can be easily connected to current shunt components. Investigator Determination if the Flusher can be activated. The following scenarios were also assessed: A noticeable resistance to compression/collapse of the dome to indicate that the Ventricular Catheter is too tightly blocked to be flushed. If the dome does not refill the Ventricular Catheter may still be non-flowing. If the dome refills, the flushing procedure may be repeated as needed and/or as determined reasonable by the surgeon.

    Intra-procedural

Study Arms (1)

Drainage with Alivio in-line Flusher

EXPERIMENTAL

Volume of saline needed to drain CSF using the Alivio in-line Flusher historically compared with volume of saline needed to drain CSF using a standard syringe

Device: Cerebrospinal Fluid (CSF) Drainage

Interventions

Placement of Alivio in line flusher during CSF drainage

Also known as: Alivio in line flusher
Drainage with Alivio in-line Flusher

Eligibility Criteria

Age30 Days - 35 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Subjects must be 30 days to 35 years of age, of any race or gender.
  • Subjects must be scheduled to undergo a neurosurgical procedure potentially requiring a revision of neurosurgical catheters.
  • Subjects aged \>18 years of age must be willing and able to provide written informed consent. Parental consent will be required for minors.

You may not qualify if:

  • Inability or unwillingness of subject or parent/guardian to give informed consent/assent.
  • Judgment of the investigator, surgeon, or any member of the care team (including anesthesiology or operating room nursing staff) that participation in the study will interfere with, or be detrimental to, administration of optimal healthcare of the subject.
  • Inability or unwillingness of subject to endure the test or any other condition that would preclude or bias the results of the study according to the judgment of the investigator.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Boston Children's Hospital

Boston, Massachusetts, 02115, United States

Location

Related Publications (2)

  • Boop FA, Medhkour A, Honeycutt J, James C, Cherny WB, Duntsch C. In vitro testing of current spread during ventricular catheter coagulation using diathermy. Technical note. J Neurosurg. 2007 Feb;106(2 Suppl):165-8. doi: 10.3171/ped.2007.106.2.165.

  • Naradzay JF, Browne BJ, Rolnick MA, Doherty RJ. Cerebral ventricular shunts. J Emerg Med. 1999 Mar-Apr;17(2):311-22. doi: 10.1016/s0736-4679(98)00168-1.

Related Links

MeSH Terms

Conditions

Hydrocephalus

Interventions

Drainage

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System Diseases

Intervention Hierarchy (Ancestors)

TherapeuticsSurgical Procedures, Operative

Results Point of Contact

Title
Director of Clinical Operations
Organization
Alcyone LifeSciences

Study Officials

  • Benjamin Warf, MD Warf, MD

    Boston Children's Hospital

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 21, 2015

First Posted

January 11, 2016

Study Start

April 1, 2016

Primary Completion

June 4, 2016

Study Completion

June 14, 2016

Last Updated

September 21, 2020

Results First Posted

September 21, 2020

Record last verified: 2020-08

Data Sharing

IPD Sharing
Will not share

Locations